Detalhe da pesquisa
1.
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
Gastroenterology
; 155(1): 210-223.e3, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29604293
2.
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
Cancer Cell
; 12(1): 66-80, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17613437
3.
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer.
Nat Commun
; 15(1): 3149, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605037
4.
Long-range function of an intergenic retrotransposon.
Proc Natl Acad Sci U S A
; 107(29): 12992-7, 2010 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615953
5.
Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
Proc Natl Acad Sci U S A
; 107(34): 15193-8, 2010 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696914
6.
Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15.
Anticancer Res
; 42(10): 4679-4687, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191971
7.
ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers.
Cancer Innov
; 1(1): 55-69, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38089448
8.
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.
J Adv Res
; 40: 109-124, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100320
9.
Smad4 Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer-Autonomous DNA-Sensing Signaling Axis.
Adv Sci (Weinh)
; 9(7): e2103029, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064757
10.
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.
J Clin Invest
; 132(24)2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282600
11.
Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling.
Redox Biol
; 38: 101780, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171331
12.
The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma.
Cell Prolif
; 53(5): e12805, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32364285
13.
A facilitated tracking and transcription mechanism of long-range enhancer function.
Nucleic Acids Res
; 35(16): 5532-44, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17704132
14.
Two Birds with One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts.
Cancer Discov
; 9(2): 173-175, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737215
15.
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization.
Cancer Commun (Lond)
; 43(2): 285-289, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251752
16.
Identification of cisplatin sensitizers through high-throughput combinatorial screening.
Int J Oncol
; 53(3): 1237-1246, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29956742
17.
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.
Sci Transl Med
; 10(464)2018 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355799
18.
NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
Cancer Lett
; 411: 44-56, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951128
19.
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.
Nat Commun
; 8: 14437, 2017 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28232723
20.
The HS2 enhancer of the beta-globin locus control region initiates synthesis of non-coding, polyadenylated RNAs independent of a cis-linked globin promoter.
J Mol Biol
; 350(5): 883-96, 2005 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-15979088